Clinical Trial Update: Study To Assess the Pharmacokinetics of AZD1656 During Coadministration With Simvastatin [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluated the interaction between AZD1656 and simvastatin in individuals with Type 2 Diabetes Mellitus; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD1656
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED